Smith & Wesson Brands
SWBI
14.51
0.00
-0.03%
Smith & Wesson Brands
US · SWBI
#3571 by market cap
14.51
0.00
-0.03%
Live - 5344 symbols - heartbeat 267s ago
· 2026-10-08 09:47
Pre-market
14.47
-0.28%
After-hours
14.49
-0.14%
- Market cap
- 650.44M
- P/E (TTM)i
- 26.37
- P/Bi
- 1.74
- EPSi
- 0.41
- Div yieldi
- 3.58%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on SWBI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.48, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +10.36% YoY
Margins
- Gross margin
- 26.94%
- Operating margin
- 5.57%
- Net margin
- 3.53%
Key ratios & quality
- Enterprise valuei
- 638.06M
- Altman Z-Scorei
- 5.48
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 481.34M | 529.62M | 1.06B | 864.13M | 479.24M | 535.83M | 474.66M | 523.85M |
| Gross profit | 146.28M | 165.69M | 448.98M | 374.56M | 154.54M | 158.09M | 127.18M | 141.10M |
| Selling & admin expenses | 94.76M | 108.02M | 121.87M | 115.65M | 98.65M | 103.74M | 96.25M | 101.60M |
| Research & development | 8.01M | 7.36M | 7.48M | 7.26M | 7.55M | 7.26M | 9.57M | 10.30M |
| Operating profit | 43.52M | 50.31M | 319.63M | 251.65M | 48.34M | 47.09M | 21.37M | 29.20M |
| Pretax profit | 34.20M | 39.18M | 317.97M | 252.39M | 48.23M | 51.72M | 19.25M | 25.07M |
| Tax | 9.28M | 11.52M | 74.39M | 57.89M | 11.35M | 10.36M | 5.82M | 6.59M |
| Net profit | 18.41M | -61.23M | 252.05M | 194.49M | 36.88M | 41.36M | 13.43M | 18.48M |
| Basic EPS | 0 | -1 | 5 | 4 | 1 | 1 | 0 | 0 |
| Diluted EPS | 0.33 | -1.11 | 4.55 | 4.08 | 0.80 | 0.89 | 0.30 | 0.41 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 140.76M | 85.08M | 124.67M | 135.71M | 178.39M | 112.59M |
| Gross profit | 40.55M | 22.07M | 30.35M | 35.59M | 53.09M | 32.27M |
| Selling & admin expenses | 25.45M | 22.07M | 23.80M | 26.65M | 29.08M | 25.50M |
| Research & development | 1.96M | 3.01M | 2.43M | 2.41M | 2.45M | 2.56M |
| Operating profit | 13.13M | -3.00M | 4.12M | 6.53M | 21.56M | 4.22M |
| Pretax profit | 12.38M | -4.10M | 3.01M | 5.37M | 20.79M | 4.02M |
| Tax | 3.74M | -690.00K | 1.09M | 1.62M | 4.57M | 1.43M |
| Net profit | 8.63M | -3.41M | 1.92M | 3.75M | 16.22M | 2.59M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.19 | -0.08 | 0.04 | 0.08 | 0.36 | 0.06 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 298.68M | 393.46M | 268.25M | 327.60M | 291.92M | 287.33M | 277.27M | 241.40M |
| Cash & ST investments | 41.02M | 125.01M | 113.02M | 120.73M | 53.56M | 60.84M | 25.23M | 33.35M |
| Inventory | 163.77M | 103.74M | 78.48M | 136.66M | 177.12M | 160.50M | 189.84M | 156.25M |
| Total assets | 766.79M | 729.52M | 446.39M | 497.48M | 541.29M | 577.43M | 559.61M | 512.77M |
| Total current liabilities | 111.28M | 129.97M | 125.66M | 88.95M | 87.21M | 94.38M | 66.64M | 75.37M |
| Short-term debt | 6.98M | 2.55M | 2.40M | 2.65M | 2.71M | 2.51M | 1.93M | 1.86M |
| Long-term debt | 149.43M | 159.17M | -- | -- | 24.79M | 39.88M | 79.10M | 19.12M |
| Total liabilities | 322,345,000.00 | 342,397,000.00 | 180,004,000.00 | 136,962,000.00 | 156,671,000.00 | 177,514,000.00 | 187,158,000.00 | 136,207,000.00 |
| Total equity | 444.44M | 387.12M | 266.38M | 360.51M | 384.62M | 399.91M | 372.45M | 376.56M |
| Retained earnings | 402.95M | 341.72M | 325.18M | 504.64M | 523.18M | 542.41M | 532.62M | 373.74M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 277.27M | 275.51M | 268.52M | 261.53M | 241.40M | 247.49M |
| Cash & ST investments | 25.23M | 21.18M | 27.32M | 23.46M | 33.35M | 25.24M |
| Inventory | 189.84M | 203.10M | 183.14M | 175.26M | 156.25M | 180.66M |
| Total assets | 559.61M | 554.63M | 548.58M | 538.00M | 512.77M | 523.30M |
| Total current liabilities | 66.64M | 52.91M | 53.89M | 58.14M | 75.37M | 68.43M |
| Short-term debt | 1.93M | 1.96M | 1.78M | 1.82M | 1.86M | 1.90M |
| Long-term debt | 79.10M | 94.15M | 88.99M | 74.06M | 19.12M | 39.19M |
| Total liabilities | 187,158,000.00 | 190,254,000.00 | 185,386,000.00 | 174,586,000.00 | 136,207,000.00 | 149,602,000.00 |
| Total equity | 372.45M | 364.38M | 363.20M | 363.42M | 376.56M | 373.70M |
| Retained earnings | 532.62M | 523.42M | 519.46M | 363.37M | 373.74M | 370.46M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 57.10M | 94.74M | 315.33M | 137.81M | 16.73M | 106.74M | -7.22M | 114.20M |
| Depreciation & amortization | 29.05M | 31.97M | 31.58M | 30.07M | 31.44M | 32.56M | 31.85M | 31.31M |
| Free cash flow | 25.99M | 81.87M | 292.65M | 113.56M | -73.17M | 15.79M | -29.02M | 90.35M |
| Dividends paid | 0 | 0 | -8.22M | -15.04M | -18.33M | -22.02M | -23.10M | -23.23M |
| Stock buybacks / issuance | 0 | 0 | -110.00M | -90.00M | 0 | -10.21M | -25.47M | 0 |
| Ending cash balance | 40.85M | 125.01M | 113.02M | 120.73M | 53.56M | 60.84M | 25.23M | 28.19M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 40.83M | -8.11M | 27.27M | 20.46M | 74.58M | -8.85M |
| Depreciation & amortization | 7.99M | 8.44M | 8.03M | 7.24M | 7.61M | 7.70M |
| Free cash flow | 33.50M | -12.46M | 16.28M | 16.82M | 69.72M | -20.79M |
| Dividends paid | -5.72M | -5.86M | -5.80M | -5.79M | -5.79M | -5.96M |
| Stock buybacks / issuance | 0 | -- | -- | 0 | 0 | -- |
| Ending cash balance | 25.23M | 17.96M | 22.43M | 18.42M | 28.19M | 18.70M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 4.25 | -14.73 | 77.14 | 62.05 | 9.90 | 10.12 | 3.48 | 4.93 |
| ROA %i | 2.44 | -8.19 | 42.89 | 41.21 | 7.10 | 7.08 | 2.36 | 3.45 |
| ROIC %i | 3.89 | -8.53 | 56.37 | 55.38 | 8.74 | 8.92 | 3.46 | 4.80 |
| 5-year avg ROE %i | 22.11 | 13.67 | 21.62 | 26.73 | 27.72 | 28.98 | 32.62 | 18.18 |
| EBIT margin %i | 5.97 | -7.18 | 30.39 | 29.45 | 10.13 | 9.60 | 5.03 | 5.70 |
| FCF / sales %i | 3.60 | 11.82 | 27.63 | 13.14 | -- | 2.95 | -- | 17.25 |
| Current ratioi | 2.68 | 3.03 | 2.13 | 3.68 | 3.35 | 3.04 | 4.16 | 3.20 |
| Quick ratioi | 1.15 | 1.44 | 1.44 | 2.08 | 1.26 | 1.29 | 1.22 | 1.03 |
| Debt / assetsi | 26.32 | 27.63 | 9.23 | 8.10 | 11.91 | 13.47 | 20.50 | 10.36 |
| LT debt / equityi | 43.84 | 51.42 | 14.56 | 10.44 | 16.05 | 18.83 | 30.29 | 13.62 |
| Interest coveragei | 4.07 | -4.35 | 82.13 | 119.21 | 146.70 | 25.04 | 5.16 | 6.21 |
| Revenue CAGR (3Y) %i | -12.68 | -16.30 | 20.40 | 21.54 | -3.28 | -20.32 | -18.10 | 3.01 |
| Net income CAGR (3Y) %i | -41.92 | -- | 132.22 | 119.42 | -- | -45.25 | -58.98 | -20.57 |
| FCF CAGR (3Y) %i | -42.63 | -2.40 | 90.11 | 63.48 | -- | -62.21 | -- | -- |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 3.48 | 3.20 | 2.52 | 2.99 | 4.93 | 6.63 |
| ROA %i | 2.36 | 2.11 | 1.63 | 1.95 | 3.45 | 4.54 |
| ROIC %i | 3.46 | 3.13 | 2.52 | 2.87 | 4.80 | 5.82 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.03 | 4.77 | 4.15 | 4.43 | 5.70 | 6.73 |
| FCF / sales %i | -- | -- | 4.53 | 11.13 | 17.25 | 14.88 |
| Current ratioi | 4.16 | 5.21 | 4.98 | 4.50 | 3.20 | 3.62 |
| Quick ratioi | 1.22 | 1.20 | 1.41 | 1.35 | 1.03 | 0.85 |
| Debt / assetsi | 20.50 | 23.32 | 22.53 | 20.17 | 10.36 | 13.90 |
| LT debt / equityi | 30.29 | 34.96 | 33.54 | 29.36 | 13.62 | 18.96 |
| Interest coveragei | 5.16 | 4.42 | 3.83 | 4.42 | 6.21 | 9.50 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Firearms100.00%
Quote time 2026-10-08 09:47:13 · For reference only, not investment advice and not tailored to your situation.